JAN 06, 2021 6:00 AM PST

COVID Patients Can't Stop and Smell the Roses

WRITTEN BY: Tara Fernandez

A study of over 2,500 European patients has revealed that 85.9 percent of those with mild COVID-19 symptoms lost their sense of smell. On average, this olfactory dysfunction lingered for around three weeks. In a quarter of patients, their sense of smell was impaired for over two months.

The study, published in the Journal of Internal Medicine, was conducted by Jerome R. Lechien from Paris Saclay University and aimed to investigate how a marked decrease in olfactory function related to the severity of COVID-19 symptoms. Interestingly, only around five percent of moderate COVID cases and seven percent of critical cases lost their sense of smell.

"Olfactory dysfunction is more prevalent in mild COVID-19 forms than in moderate-to-critical forms, and 95% of patients recover their sense of smell at 6-months post-infection," said Lechien.

The temporary loss of smell, also known as anosmia, has been touted by experts as a better diagnostic indicator of the onset of infection than other common symptoms such as fever and cough. 

 

 

But why does SARS-CoV-2 infection interrupt patients’ ability to smell? Scientists initially suspected that the virus might be impacting the olfactory sensory neurons that detect and relay chemical signals from the nose to the brain. Follow up studies proved this not to be the case, as these neurons do not express the ACE2 receptor protein, the gateway for the coronavirus to enter human cells. 

Instead, SARS-CoV-2 is likely affecting the olfactory neurons’ support network—stem cells and cells lining blood vessels in the nasal passage. 

“Our findings indicate that the novel coronavirus changes the sense of smell in patients not by directly infecting neurons but by affecting the function of supporting cells,” explained Harvard Medical School scientist Sandeep Robert Datta.

On a positive note, COVID-related anosmia is a temporary condition.

“I think it’s good news, because once the infection clears, olfactory neurons don’t appear to need to be replaced or rebuilt from scratch,” added Datta. “But we need more data and a better understanding of the underlying mechanisms to confirm this conclusion.”

Sources: Harvard Medical School, Journal of Internal Medicine, EurekAlert.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JAN 13, 2021
Clinical & Molecular DX
E-Stethoscope Picks up Good (and Bad) Vibrations
JAN 13, 2021
E-Stethoscope Picks up Good (and Bad) Vibrations
A medical device used to survey lung sounds to monitor for signs of respiratory distress has received FDA clearance. RES ...
JAN 22, 2021
Clinical & Molecular DX
Breast Cancer's Nasty Nine Revealed
JAN 22, 2021
Breast Cancer's Nasty Nine Revealed
Calculating an individual’s risk of developing breast cancer isn’t easy. There’s a complex interplay b ...
FEB 01, 2021
Genetics & Genomics
As Many as 20% of Patients Would Benefit From Pharmacogenetic Testing
FEB 01, 2021
As Many as 20% of Patients Would Benefit From Pharmacogenetic Testing
Researchers have suggested that a simple genetic test could be a huge benefit to public health; it could tell clinicians ...
FEB 23, 2021
Genetics & Genomics
New Insight Into Genetic Basis of IBD From African-American Patients
FEB 23, 2021
New Insight Into Genetic Basis of IBD From African-American Patients
The small variations in the genome that lead to differences in biology, including risk for diseases, can't be assumed to ...
MAR 25, 2021
Clinical & Molecular DX
Police Speeding Radar Technology Used to Catch Antibiotic-Resistant Bacteria
MAR 25, 2021
Police Speeding Radar Technology Used to Catch Antibiotic-Resistant Bacteria
Doppler radars are used by cops to catch speeding drivers, in spacecraft navigation, and for forecasting the weather. No ...
APR 15, 2021
Clinical & Molecular DX
A Portable Ebola Detector, 1000x More Sensitive Than Lab-Based Tests
APR 15, 2021
A Portable Ebola Detector, 1000x More Sensitive Than Lab-Based Tests
Duke University scientists have created a highly sensitive Ebola virus portable diagnostic device, 1000 times more sensi ...
Loading Comments...